Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines

Biomaterials

Volumn 27, Issue 34, 2006, Pages 5755-5762

  Yushin, Gleb ^a   Hoffman, Elizabeth N ^a   Barsoum, Michel W ^a   Gogotsi, Yury ^a   Howell, Carol A ^b   Sandeman, Susan R ^b   Phillips, Gary J ^b   Lloyd, Andrew W ^b   Mikhalovsky, Sergey V ^b  

^a Drexel University   (United States)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Adsorption; Carbon; Cytokine; Protein adsorption

Indexed keywords

CYTOKINE; INFLAMMATORY MEDIATORS; PROTEIN ADSORPTION;

ADSORPTION; ANTIBODIES; ANTIGENS; DISEASES; IMMUNOLOGY; MESOPOROUS MATERIALS;

PROTEINS;

CARBON; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; HUMAN; POROSITY; PRIORITY JOURNAL; SYNTHESIS;

ADSORPTION; CARBON; CYTOKINES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; POROSITY; SURFACE PROPERTIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747853561     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.07.019     Document Type: Article

References (38)

1. Slade E., Tamber P.S., and Vincent J.L. The surviving sepsis campaign: raising awareness to reduce mortality. Crit Care 7 1 (2003) 1-2
2. Williams M.D., Braun L.A., Cooper L.M., Johnston J., Weiss R.V., Qualy R.L., et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 8 5 (2004) R291-R298
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
4. Asachenkov A., Marchuk G., Mohler R., and Zuev S. Immunology and disease control: a system approach. IEEE Trans Biomed Eng 41 (1994) 943-953
5. Callard R., George A., and Stark J. Cytokines, chaos, and complexity. Immunity 11 (1999) 507-513
6. Neugebauer E., Willy C., and Sauerland S. Complexity and non-linearity in shock research: reductionism or synthesis?. Shock 16 (2001) 252-258
7. Natanson C., Esposito C.J., and Banks S.M. The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. Crit Care Med 26 (1998) 1927-1931
8. Mikhalovsky S.V. Emerging technologies in extracorporeal treatment: Focus on adsorption. Perfusion-UK 16 2 (2003) 47-54
9. Sandeman S.R., Howell C.A., Phillips G.J., Lloyd A.W., Davies J.G., Mikhalovsky S.V., et al. Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis. Biomaterials 26 34 (2005) 7124-7131
10. Ryoo R., Joo S.H., and Jun S. Synthesis of highly ordered carbon molecular sieves via template-mediated structural transformation. J Phys Chem B 103 37 (1999) 7743-7746
11. Xia Y.D., and Mokaya R. Ordered mesoporous carbon hollow spheres nanocast using mesoporous silica via chemical vapor deposition. Adv Mater 16 11 (2004) 886-891
12. Lee J., Han S., and Hyeon T. Synthesis of new nanoporous carbon materials using nanostructured silica materials as templates. J Mater Chem 14 4 (2004) 478-486
13. Gogotsi Y., Nikitin A., Ye H., Zhou W., Fischer J.E., Yi B., et al. Nanoporous carbide-derived carbon with tunable pore size. Nat Mater 2 (2003) 591-594
14. Dash R.K., Yushin G., and Gogotsi Y. Nanoporous carbon derived from zirconium carbide. Micropor Mesopor Mater 86 (2005) 50-57
15. Dash RK, Yushin G, Laudisio G, Fischer JE, Gogotsi Y. Titanium carbide-derived nanoporous carbon for energy-related applications. Carbon, 2006, in press, doi:10.1016/j.carbon.2006.04.035.
16. Dash R.K., Nikitin A., and Gogotsi Y. Microporous carbon derived from boron carbide. Micropor Mesopor Mater 72 (2004) 203-208
17. Barsoum B.M., and El-Raghy T. The MAX phases: unique new carbide and nitride materials. Am Sci 89 (2001) 334-343
18. N phases: a new class of solids. Prog Solid State Chem 28 (2000) 201-281
19. Yushin G., Hoffman E., Nikitin A., Ye H., Barsoum M.W., and Gogotsi Y. Synthesis of nanoporous carbide-derived carbon by chlorination of titanium silicon carbide. Carbon 44 10 (2005) 2075-2082
20. Hoffman E., Yushin G.N., Barsoum B.M., and Gogotsi G. Synthesis of nanoporous carbide-derived carbon by chlorination of titanium aluminum carbide. Chem Mater 17 9 (2005) 2317-2322
21. Yushin G., Gogotsi Y., and Nikitin A. Carbide derived carbon. In: Gogotsi Y. (Ed). Nanomaterials handbook (2005), CRC Press, Boca Raton, FL 239-282
22. Ravikovitch P.I., and Neimark A.V. Characterization of nanoporous materials from adsorption and desorption isotherms. Colloids Surf A: Phys Eng Aspects 187-188 (2001) 11-21
23. Brunauer S., Emmett P., and Teller E. Adsorption of gases in multimolecular layers. J Am Chem Soc 60 (1938) 309-319
24. Gregg S.J., and Sing K.S.W. Adsorption, Surface Area and Porosity (1982), Academic Press, London
25. Lowell S, Schields JE. Powder surface area and porosity, New York, 1998.
26. Cohen J., and Abraham E. Microbiological findings and correlations with serum tumour necrosis factor alpha in patients with severe septic shock. J Infect Dis 180 (1999) 116-121
27. Heering P., Morgera S., Schmitz F.J., Schmitz G., Willers R., Schultheiss H.P., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Int Care Med 23 (1997) 228-296
28. Marum S., Riberio J.P., Arranhado E., Lage H., Mota L., Marcelino P., et al. Cytokines and sepsis-just black smoke. Crit Care Med 4 (2000) 66
29. Reed C., Fu Z.Q., Wu J., Xue Y.N., Harrison R.W., Chen M.J., et al. Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2. Protein Eng 10 10 (1997) 1101-1107
30. Kellum J.A., Song M.C., and Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappa B DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 32 3 (2004) 801-805
31. Weber V., Linsberger I., Ettenauer M., Loth F., Hoyhtya M., and Falkenhagen D. Development of specific adsorbents for human tumor necrosis factor-alpha: influence of antibody immobilization on performance and biocompatibility. Biomacromolecules 6 4 (2005) 1864-1870
32. Hinterdorfer P., Baumgartner W., Gruber H.J., Schilcher K., and Schindler H. Detection and localization of individual antibody-antigen recognition events by atomic force microscopy. Proc Natl Acad Sci USA 93 8 (1996) 3477-3481
33. Einspahr H., Clancy L.L., Muchmore S.W., Watenpaugh K.D., Harris P.K.W., Carter D.B., et al. Crystallization of recombinant human interleukin 1-beta. J Cryst Growth 90 1-3 (1988) 180-187
34. Somers W., Stahl M., and Seehra J.S. 1.9 angstrom crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. Embo J 16 5 (1997) 989-997
35. Rajarathnam K., Clarklewis I., and Sykes B.D. H-1-Nmr solution structure of an active monomeric interleukin-8. Biochemistry 34 40 (1995) 12983-12990
36. Reinhart K., Meier-Hellmann A., Beale R., Forst H., Boehm D., Willatts S., et al. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis. Crit Care Med 32 8 (2004) 1662-1668
37. Cole L., Bellomo R., Hart G., Journois D., Davenport P., Tipping P., et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30 1 (2002) 100-106
38. Fan R., Karnik R., Yue M., Li D.Y., Majumdar A., and Yang P.D. DNA translocation in inorganic nanotubes. Nano Lett 5 9 (2005) 1633-1637